MiNK Therapeutics (INKT) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.8
-0.56
-0.31
-0.07

Details

Expected EPS
-0.800667
Actual EPS
-0.5
Surprise EPS
0.3
Surprise Percent
+37.55%

Description

⁨MiNK Therapeutics⁩ (⁦INKT⁩) has reported earnings of ⁦-0.5⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts